Restricted accessResearch articleFirst published online 2025
“This Disease Is a Verdict You Must Live With for the Rest of Your Life”: Experiences and Perspectives From People Living With Adult-Onset Myotonic Dystrophy Type 1
Myotonic dystrophy type 1 (DM1) is a progressive, multisystemic neuromuscular disease. DM1 has a biopsychosocial impact, causing physical and cognitive impairment and limitations in activity and participation as well as having social consequences. The aim of our study was to investigate experiences of and perspectives on living and coping with adult-onset DM1 to inform future targeted rehabilitation services. We conducted semi-structured individual interviews with 25 people with adult-onset DM1. Observational notes were taken during the interviews. Our study used the interpretive description methodology and Herbert Blumer’s theory of Symbolic Interactionism as the theoretical lens. The analysis identified two categorical themes and six subthemes: The meaning of living with DM1 and DM1’s influence on relations. Our findings showed that participants with adult-onset DM1 found meaning in their disease by reflecting on being diagnosed, understanding health information, and how DM1 influences daily living. Additionally, DM1 affected the participants’ interactions with others, thereby also influencing their relations. Our study contributes insights into how the intricate interaction with social relations and surroundings contributes to finding meaning when living with adult-onset DM1.
AllergodtK.DreyerP.WerlauffU.HandbergC. (2024). Living with adult-onset myotonic dystrophy type 1: A scoping review. Disability & Rehabilitation, 47(9), 2246–2257. https://doi.org/10.1080/09638288.2024.2396063
2.
AllergodtK.HandbergC.FrostA.WerlauffU. (2022). A retrospective study of needs and interventions among patients with myotonic dystrophy type 1 in Denmark referred to rehabilitation in the period 2000-2019. Journal of Evaluation in Clinical Practice, 29(1), 39–48. https://doi.org/10.1111/jep.13706
3.
AshizawaT.GagnonC.GrohW. J.GutmannL.JohnsonN. E.MeolaG.MoxleyR.3rdPandyaS.RogersM. T.SimpsonE.AngeardN.BassezG.BerggrenK. N.BhaktaD.BozzaliM.BroderickA.ByrneJ. L.CampbellC.CupE. H.WinbladS. (2018). Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurology: Clinical Practice, 8(6), 507–520. https://doi.org/10.1212/CPJ.0000000000000531
4.
BaldanziS.BevilacquaF.LorioR.VolpiL.SimonciniC.PetrucciA.CosottiniM.MassimettiG.TognoniG.RicciG.AngeliniC.SicilianoG. (2016). Disease awareness in myotonic dystrophy type 1: An observational cross-sectional study. Orphanet Journal of Rare Diseases, 11(34), Article 34. https://doi.org/10.1186/s13023-016-0417-z
5.
BlumerH. (1986). Symbolic interactionism: Perspective and method. University of California Press.
6.
CheungM. M. Y.LewisS.RajaR.WillisK.DubbinL.RogersA.MoenstedM. L.SmithL. (2024). Disruption and improvisation: Experiences of loneliness for people with chronic illness. Qualitative Health Research, 35(3), 319–334. https://doi.org/10.1177/10497323241265329
7.
ConradssonD.YtterbergC.EngelkesC.JohanssonS.GottbergK. (2021). Activity limitations and participation restrictions in people with multiple sclerosis: A detailed 10-year perspective. Disability & Rehabilitation, 43(3), 406–413. https://doi.org/10.1080/09638288.2019.1626919
8.
CupE. H.KinébanianA.SatinkT.PieterseA. J.HendricksH. T.OostendorpR. A.van der WiltG. J.van EngelenB. G. (2011). Living with myotonic dystrophy; what can be learned from couples? A qualitative study. BMC Neurology, 11, Article 86. https://doi.org/10.1186/1471-2377-11-86
9.
De AntonioM.DoganC.HamrounD.MatiM.ZerroukiS.EymardB.KatsahianS.BassezG.French Myotonic Dystrophy Clinical Network. (2016). Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification. Revue Neurologique, 172(10), 572–580. https://doi.org/10.1016/j.neurol.2016.08.003
10.
De Araújo EvangelistaM.DiasF. A. L.DouradoM. E. T.Do NascimentoG. C.SarmentoA.GualdiL. P.AlivertiA.ResquetiV.De Freitas FregoneziG. A. (2017). Noninvasive assessment of respiratory muscle strength and activity in myotonic dystrophy. PLoS One, 12(6), Article e0177318. https://doi.org/10.1371/journal.pone.0177318
11.
de Die-SmuldersC. E. M.HöwelerC. J.ThijsC. T. M.MirandolleJ. F.AntenH. B.SmeetsH. J. M.ChandlerK. E.GeraedtsJ. P. M. (1998). Age and causes of death in adult-onset myotonic dystrophy. Brain, 121(8), 1557–1563. https://doi.org/10.1093/brain/121.8.1557
12.
GagnonC.MathieuJ.NoreauL. (2007). Life habits in myotonic dystrophy type 1. Journal of Rehabilitation Medicine, 39(7), 560–566. https://doi.org/10.2340/16501977-0091
13.
GourdonG.MeolaG. (2017). Myotonic dystrophies: State of the art of new therapeutic developments for the CNS. Frontiers in Cellular Neuroscience, 11, Article 101. https://doi.org/10.3389/fncel.2017.00101
14.
HandbergC.JensenA. L. (2021). Interpretive Description: En Anvendelsesorienteret Forskningsmetodologi [Interpretive description: An applied research methodology]. Aarhus Universitetsforlag.
15.
HandbergC.ThorneS.MidtgaardJ.NielsenC. V.LomborgK. (2015). Revisiting symbolic interactionism as a theoretical framework beyond the grounded theory tradition. Qualitative Health Research, 25(8), 1023–1032. https://doi.org/10.1177/1049732314554231
16.
HarperP. S.van EngelenB. G. M.EymardB.WilcoxD. E. (2004). Myotonic dystrophy: Present management, future therapy. Oxford University Press.
17.
HeatwoleC.BodeR.JohnsonN.QuinnC.MartensW.McDermottM. P.RothrockN.ThorntonC.VickreyB.VictorsonD.MoxleyR.3rd (2012). Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology, 79(4), 348–357. https://doi.org/10.1212/WNL.0b013e318260cbe6
18.
HilbertJ. E.AshizawaT.DayJ. W.LuebbeE. A.MartensW. B.McDermottM. P.TawilR.ThorntonC. A.MoxleyR. T. (2013). Diagnostic odyssey of patients with myotonic dystrophy. Journal of Neurology, 260(10), 2497–2504. https://doi.org/10.1007/s00415-013-6993-0
JohnsonN. E.HeatwoleC. R. (2012). Myotonic dystrophy: From bench to bedside. Seminars in Neurology, 32(3), 246–254. https://doi.org/10.1055/s-0032-1329202
21.
LaDonnaK. A.GhavaniniA. A.VenanceS. L. (2015). Truths and misinformation: A qualitative exploration of myotonic dystrophy. The Canadian Journal of Neurological Sciences, 42(3), 187–194. https://doi.org/10.1017/cjn.2015.26
22.
LaDonnaK. A.VenanceS. L. (2015). Picturing the experience of living with myotonic dystrophy (DM1): A qualitative exploration using photovoice. Journal of Neuroscience Nursing, 47(5), 285–295. https://doi.org/10.1097/jnn.0000000000000160
23.
LaDonnaK. A.WatlingC. J.RayS. L.PiechowiczC.VenanceS. L. (2017). Evolving motivations: Patients’ and caregivers’ perceptions about seeking myotonic dystrophy (DM1) and Huntington’s disease care. Qualitative Health Research, 27(11), 1727–1737. https://doi.org/10.1177/1049732317711901
24.
LandfeldtE.NikolenkoN.Jimenez-MorenoC.CummingS.MoncktonD. G.GormanG.TurnerC.LochmüllerH. (2019). Disease burden of myotonic dystrophy type 1. Journal of Neurology, 266(4), 998–1006. https://doi.org/10.1007/s00415-019-09228-w
25.
LiaoQ.ZhangY.HeJ.HuangK. (2022). Global prevalence of myotonic dystrophy: An updated systematic review and meta-analysis. Neuroepidemiology, 56(3), 163–173. https://doi.org/10.1159/000524734
26.
MalterudK.SiersmaV. D.GuassoraA. D. (2016). Sample size in qualitative interview studies: Guided by information power. Qualitative Health Research, 26(13), 1753–1760. https://doi.org/10.1177/1049732315617444
27.
MathieuJ.BoivinH.MeunierD.GaudreaultM.BeginP. (2001). Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy. Neurology, 56(3), 336–340. https://doi.org/10.1212/WNL.56.3.336
28.
MeolaG. (2013). Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies. Acta Myologica, 32(3), 154–165.
29.
OkkersenK.BuskesM.GroenewoudJ. M. M.KesselsR. P. C.KnoopH.van EngelenB.RaaphorstJ. (2017). The cognitive profile of myotonic dystrophy type 1: A systematic review and meta-analysis. Cortex, 95, 143–155. https://doi.org/10.1016/j.cortex.2017.08.008
30.
PetriH.MohammadB. J. Y.KristensenA. T.ThuneJ. J.VissingJ.KøberL.WittingN.BundgaardH.ChristensenA. H. (2024). Natural history of cardiac involvement in myotonic dystrophy type 1 – Emphasis on the need for lifelong follow-up. International Journal of Cardiology, 406, Article 132070. https://doi.org/10.1016/j.ijcard.2024.132070
31.
PetriH.WittingN.ErsbøllM. K.SajadiehA.DunøM.Helweg-LarsenS.VissingJ.KøberL.BundgaardH. (2014). High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: A cross-sectional study. International Journal of Cardiology, 174(1), 31–36. https://doi.org/10.1016/j.ijcard.2014.03.088
UddB. D.KraheR. D. (2012). The myotonic dystrophies: Molecular, clinical, and therapeutic challenges. The Lancet Neurology, 11(10), 891–905. https://doi.org/10.1016/S1474-4422(12)70204-1
41.
von der LippeC.DiesenP. S.FeragenK. B. (2017). Living with a rare disorder: A systematic review of the qualitative literature. Molecular Genetics & Genomic Medicine, 5(6), 758–773. https://doi.org/10.1002/mgg3.315
42.
WerlauffU.RudolfsenJ. H.AndersenH.VissingJ.RossauC. D.DreyerP.OlsenJ.BengtssonS. D.AagaardH.HandbergC. (2025). Multiorgan involvement and mortality in individuals with adult-onset myotonic dystrophy (DM1) - A Danish register-based study I. European Journal of Neurology, 32(4), Article e70135. https://doi.org/10.1111/ene.70135
